Effect of Vitamin D as Adjuvant Therapy in Preterm Infants With Neonatal Sepsis
A legfontosabb adatok
- Ki végzi
- Universitas Padjadjaran
- Hol
- Indonézia2 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Fázis
- 4. fázis
- Résztvevők
- 78 fő vett részt
- Kezdés
- 2025. aug. 2.
- Befejezés
- 2025. dec. 8.
- A vizsgálat típusa
- Beavatkozással járó, 3 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Vitamin D
- A regiszteradat frissítve
- 2026. február 5.
Ki vehet részt
- Életkor
- 0 nap – 84 nap
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 5 feltétel megnézéseKevesebb
Ki vehet részt
- Patients diagnosed with neonatal sepsis based on positive blood or cerebrospinal fluid cultures, or who meet the criteria for suspected sepsis with a Rodwell hematologic scoring system result of ≥3
- Parents or legal guardians are willing to participate in the study and sign the informed consent form
Ki nem vehet részt
- Patients with major congenital malformations such as anencephaly, encephalocele, holoprosencephaly, hydrocephalus, meningomyelocele, spina bifida, omphalocele, gastroschisis, or congenital heart disease
- If during the 7-day monitoring period, a patient who was initially able to feed develops a medical condition requiring fasting (NPO)
- If during the 7-day monitoring period, a patient who initially had a medical condition requiring fasting is later able to feed again
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to learn the effect of vitamin D as an adjunctive therapy for preterm neonates with sepsis measured by the outcomes, which are sepsis score and C-reactive protein after 7 days. The main questions it aims to answer are:
A teljes eredeti leírásKevesebb
Is there a difference in the results of the sepsis score (Modified Tollner Score and Sepsis Prediction Score) between groups of preterm neonates with sepsis who were given vitamin D as adjuvant therapy at doses of 400 IU/day, 800 IU/day, and those who were only given antibiotics?
Is there a difference in CRP levels between groups of preterm neonates with sepsis who were given vitamin D as adjuvant therapy at doses of 400 IU/day, 800 IU/day, and those who were only given antibiotics?
Participants will be divided into 3 groups:
Group 1 consisted of subjects who were given only antibiotics due to medical conditions requiring fasting.
Group 2 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 400 IU once daily for 7 days.
Group 3 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 800 IU once daily for 7 days.
A vizsgálat 3 csoportja
- Antibiotics onlyNincs vizsgálati kezelés, összehasonlításként
Group 1 consisted of subjects who were given only antibiotics due to medical conditions requiring fasting.
- Vitamin D 400 IUMár használt kezelés, összehasonlításként
Group 2 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 400 IU once daily for 7 days.
Kezelés: Vitamin D
- Vitamin D 800 IUMár használt kezelés, összehasonlításként
Group 3 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 800 IU once daily for 7 days.
Kezelés: Vitamin D
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- The Effect of Vitamin D Administration on Sepsis Score and C-Reactive Protein Levels in Preterm Infants With Neonatal Sepsis
- Publikációk
- A regiszteradat frissítve
- 2026. február 5.